SCHEMBL19167076

SCHEMBL19167076

c1ccc(-c2ccc(-c3nc(-c4ccc(-c5cccnc5)cc4)cc(-c4cc5c6ccccc6c6ccccc6c5c5ccccc45)n3)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 1/20 0.51
▸ CYP19A1 P11511 2/20 0.49
▸ CYP11B1 P15538 2/20 0.47
▸ KDM4E B2RXH2 4/20 0.44
▸ GLA P06280 3/20 0.44
▸ GAA P10253 1/20 0.44
▸ ALDH1A1 P00352 6/20 0.43
▸ MEN1 O00255 4/20 0.43
▸ KMT2A Q03164 4/20 0.43
▸ MAPT P10636 4/20 0.43
▸ HPGD P15428 3/20 0.43
▸ NTSR1 P30989 1/20 0.43
▸ CYP3A4 P08684 4/20 0.43
▸ CYP1A2 P05177 3/20 0.43
▸ CLK4 Q9HAZ1 3/20 0.43
▸ CYP2C9 P11712 3/20 0.43
▸ CYP2D6 P10635 2/20 0.43
▸ TSHR P16473 2/20 0.43
▸ CYP17A1 P05093 1/20 0.42
▸ CYP11B2 P19099 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19168298 1.00 DHODH (0.51) DHODHCYP19A1CYP11B1KDM4EGLA
SCHEMBL19168332 1.00 DHODH (0.51) DHODHCYP19A1CYP11B1KDM4EGLA
SCHEMBL19166367 1.00 DHODH (0.51) DHODHCYP19A1CYP11B1KDM4EGLA
SCHEMBL19167756 0.95 DHODH (0.51) DHODHCYP19A1CYP11B1KDM4EGLA
SCHEMBL19166371 0.95 DHODH (0.51) DHODHCYP19A1CYP11B1KDM4EGLA
SCHEMBL19167770 0.95 DHODH (0.51) DHODHCYP19A1CYP11B1KDM4EGLA
SCHEMBL19167064 0.95 DHODH (0.51) DHODHCYP19A1CYP11B1KDM4EGLA
SCHEMBL19166599 0.95 DHODH (0.51) DHODHCYP19A1CYP11B1KDM4EGLA
SCHEMBL19168484 0.95 DHODH (0.51) DHODHCYP19A1CYP11B1KDM4EGLA
SCHEMBL19167802 0.95 DHODH (0.51) DHODHCYP19A1CYP11B1KDM4EGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10797244-B2 Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2020-10-06 — — US disclosed
US-20170213982-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-07-27 — — US disclosed
US-20170213982-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-07-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10797244-B2 Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device RER1, RBM12, H1-2 DHODH 4664/4885CYP19A1 716/4885CYP11B1 2171/4885
US-20170213982-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE RER1, RBM12, H1-2 DHODH 4664/4885CYP19A1 716/4885CYP11B1 2171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback